ABION Inc. (KOSDAQ:203400)
South Korea · Delayed Price · Currency is KRW 980.00
+139.00 (16.53%)
At close: Aug 11, 2026
ABION Market Cap
ABION has a market cap or net worth of 88.3 billion as of August 11, 2026. Its market cap has decreased by -52.11% in one year.
Market Cap
88.30B
Enterprise Value
79.24B
Revenue
1.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
980.00
ChartMarket Cap Chart
Since April 5, 2017, ABION's market cap has increased from 54.88B to 88.30B, an increase of 60.89%. That is a compound annual growth rate of 5.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 88.30B | -68.69% |
| Dec 30, 2025 | 282.02B | 40.69% |
| Dec 30, 2024 | 200.46B | 22.52% |
| Dec 28, 2023 | 163.61B | 29.00% |
| Dec 29, 2022 | 126.83B | -53.68% |
| Dec 30, 2021 | 273.81B | 220.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cell Biotech | 110.46B |
| CORESTEMCHEMON | 101.81B |
| Choong Ang Vaccine Laboratory | 86.64B |
| EyeGene | 84.30B |
| SunBio,Inc. | 81.70B |
| CTCBIO | 80.45B |
| BIO-FD&C | 72.17B |
| QuadMedicine | 70.04B |